InvestorsHub Logo
Post# of 252636
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: biotech jim post# 120675

Friday, 05/27/2011 1:36:37 PM

Friday, May 27, 2011 1:36:37 PM

Post# of 252636

Master, don't you have these odds [odds of success in non-carrier near 60% and carrier around 25%] reversed?

I think he meant what he wrote because in phase II, the post-hoc ApoE4 subgroups analysis showed good efficacy only in non-carriers.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.